Isabelle De Walsche – Managing Director, Gedeon Richter BeNeLux
Isabelle De Walsche, managing director of Gedeon Richter in Belgium, the Netherlands, and Luxembourg gives an…
Gedeon Richter
Last updated: 13.02.2014
Address: Gyömrői út 19-21, H-1103 Budapest, Hungary,Hungary
Tel: (+36) 1-431-4000
Web: http://www.richter.hu/HU/Pages/home.aspx
Company description
Gedeon Richter Plc. is a Hungarian-controlled Central-Eastern European multinational pharmaceutical company. The parent company and its manufacturing subsidiaries in four countries combine to form the region’s leading pharmaceutical manufacturing group. The Company’s products are available, through its own distribution network, to the inhabitants of some 100 different countries.
Products and services
Our activity includes research, development, manufacture and marketing of human finished drugs, active substances and intermediates.
Interviews
Corina Croitoru – Managing Director of Marketing, Czech Republic and…
With a footprint of over 20 years in the Czech Republic, Gedeon Richter’s affiliate here is a key pillar to the…
Gábor Orbán – CEO, Gedeon Richter
Gábor Orbán, CEO of Gedeon Richter, highlights the recent turnaround of the company’s performance, its…
Andras Gizur – President China & APAC, Gedeon Richter
Andras Gizur, president China & APAC for Gedeon Richter, shares his insights on the current market environment…
Emmanuel Eumont – General Manager, Gedeon Richter France
Emmanuel Eumont, general manager of Gedeon Richter France, discusses the group’s leading position in women’s…
Interview: Corina Croitoru – Country Manager, Gedeon Richter Slovakia
Corina Croitoru of Gedeon Richter Slovakia discusses GR’s footprint in the country, the affiliate’s main growth…
Interview: Giovanna Labbate – Country Manager, Gedeon Richter, Italy
Country Manager Giovanna Labbate talks how Gedeon Richter aims to become the point of reference for women’s…
Interview: Isabelle De Walsche – Managing Director, Gedeon Richter…
Isabelle de Walsche, Managing Director of Gedeon Richter Benelux, provides us with an update on the development of…
Interview: Ksenija Pavletic – CEO PregLem & President Gedeon Richter,…
The president of Gedeon Richter France and CEO of PregLem, a Swiss-based biotech company acquired by Gedeon Richter…
Interview with František Gyürüsi, Managing Director, Gedeon Richter Czech…
Mr. Gyürüsi, Gedeon Richter is a 111-year-old company that is synonymous with the Central and Eastern…
Interview with Andras Gizur, Chief Representative, Gedeon Richter
Since establishing Gedeon Richter’s operations here 16 years ago, you’ve been involved in the full…
Erik Bogsch – Managing Director, Gedeon Richter
Gedeon Richter’s Erik Bogsch discusses the company’s 100th anniversary, it’s growing…
Related
China / Boehringer Ingelheim's Stroke Rehab Centre Success & Continuing China Push
In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…
Haijun Dong – CEO, BioDuro-Sundia
Dr Haijun Dong, recently appointed CEO of BioDuro-Sundia, shares his priorities for the newly merged entity, one of…
China / Public Insurance Coverage for Rare Disease Patients: Beijing & Shanghai Surprisingly Low in New City Ranking
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare Disorders (CORD), outlines the…
China / AstraZeneca/Junshi anti-PD-1 Tie-Up; New UK Biologics Plan for Pharmaron; Clover’s $230 Million Investment Boost
The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and…
China / Yangtze River Pharmaceutical Group (YRPG) in Profile
One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River…
China / HiFiBiO CEO on the Keys to Global Biotech Success
HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T:…
China / New Drug Approvals 2020
Writing in the February edition of DIA’s Global Forum magazine, Xu Wang of Novo Nordisk Pharma China and Xiaoxi…
Liang Schweizer – CEO & CSO, HiFiBiO Therapeutics
Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the…
China / National Reimbursement Drug List (NRDL) 2020: What Reward for Innovation?
Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…
China / New Year, New Round of Drug Price Cuts
Since China first announced its ground-breaking volume-based procurement (VBP) pilot program to reduce drug…
China / 5 Top Trends in Healthcare & Biopharma in 2020
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being…
Global / 2020's Top 7 Biotech IPOs In Profile
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you profiles of…
